With support from the Collaborative R&D grant from the Technology Strategy Board (TSB), Neotherix has employed a Biomaterials Scientist to develop the scaffold-hydrogel composite component of the RegeniTherix™ wound care device and point-of-care diagnostic system.

Seconded for one year to the Centre for Biomolecular Sciences at the University of Nottingham, Lorenzo Pio Serino is developing the reversible hydrogel that will be integrated with our bioresorbable scaffold technology. As described in previous news items on 08/04/08 and 07/08/08, the RegeniTherix consortium is developing a novel wound device incorporating both a biodegradable tissue scaffold and a removable hydrogel layer to enable detailed and rapid evaluation of the wound.

See this article on TheBusinessDesk.com (registration required)

Link to the Centre for Biomolecular Sciences, University of Nottingham